Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo

Journal Article · · International Journal of Radiation Oncology, Biology and Physics; (United States)
; ;  [1];  [2];  [3]
  1. Brown Univ., Providence, RI (United States)
  2. Syntex Corp., Palo Alto, CA (United States)
  3. Cleveland Clinic Foundation, OH (United States)
To determine the quantitative responses to x-irradiation of exponentially growing human prostatic cancer cell lines PC-3 and DU-145 in vitro, and to determine the hypoxic percentages of these two cell lines when grown in vivo as xenografted solid tumors in nude mice. Radiation survival in vitro was quantitated using both single-hit, multitarget and linear-quadratic formalisms. Hypoxic fractions in vivo were determined from tumors of average sizes of about 750 mm[sup 3] using clonogenic excision assay. The data from the in vitro experiments show that the DU-145 cell line is significantly more radioresistant than the PC-3 cell line. In vivo, the DU-145 tumors exhibit a significantly lower hypoxic percentage than do PC-3 neoplasms. Results indicate that significantly variability exists within human prostate tumors in regard to both intrinsic radiosensitivity in vitro and levels of hypoxia in vivo. Because these data appear to be the first published information on the intrinsic radiosenstivity and intratumor hypoxia characteristics of human prostate cancer, additional studies are needed to define the distributional aspects of these clinically relevant endpoints.
OSTI ID:
6611089
Journal Information:
International Journal of Radiation Oncology, Biology and Physics; (United States), Journal Name: International Journal of Radiation Oncology, Biology and Physics; (United States) Vol. 25:2; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English